Saturday, March 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Outbreak News

Relief Funds Being Used to Pay Hospital Shareholders at the Expense of Frontline Health Care Workers

by Global Biodefense Staff
July 2, 2020
Relief Funds Being Used to Pay Hospital Shareholders at the Expense of Frontline Health Care Workers

Soldiers and Airmen of the Mississippi National Guard gather at the entrance to the University of Mississippi Medical Center to honor civilian healthcare workers during National Nurses Week in Jackson, Miss., May 6, 2020. The Guardsmen cheered for UMMC employees as they entered and exited the hospital during morning shift change and thanked them for their work during the COVID-19 pandemic. (U.S. Army National Guard photo by Spc. Jovi Prevot)

U.S. Senator Tammy Baldwin is raising questions for U.S. Health and Human Services Secretary Alex Azar about the use of funding appropriated by Congress to the Public Health and Social Services Emergency Fund being used to pay shareholders and private equity owners at the expense of frontline health care workers.

In the Baldwin-led letter to Secretary Azar, signed by Senators Richard Blumenthal (D-CT), Sherrod Brown (D-OH), Kamala Harris (D-CA), Patrick Leahy (D-VT), Ed Markey (D-MA), Chris Murphy (D-CT), Bernie Sanders (I-VT) and Elizabeth Warren (D-MA), they write:

“We are deeply concerned that HHS has not placed adequate limits on the extent to which wealthy health care companies can use taxpayer funding to line the pockets of executives and private equity owners, while cutting pay, furloughing, or firing doctors, nurses, and other essential workers that are preventing the spread of COVID-19 and saving lives—often without adequate personal protective equipment.  Such payments to shareholders at the expense of frontline health care workers are inconsistent with the goal of the Fund and therefore we ask that you prohibit them.”

Legislation passed by Congress, including the Coronavirus Aid, Relief, and Economic Security (CARES) Act and the Paycheck Protection Program and Health Care Enhancement Act, has provided $175 billion to the Public Health and Social Services Emergency Fund in order to provide relief for health care providers. The HHS website states that the Provider Relief Fund “supports American families, workers, and the heroic healthcare providers in the battle against the COVID-19 outbreak.” The terms and conditions of the program require providers to certify that the payment will only be used to “prevent, prepare for, and respond to coronavirus, and that the payment shall reimburse the recipient only for health care related expenses or lost revenues that are attributable to coronavirus.” 

However, as the New York Times has reported, dozens of the top recipients of government aid have laid off, furloughed or cut the pay of tens of thousands of employees as CEO’s got millions of bailout dollars. In addition, a Bloomberg News analysis found that private equity companies have borrowed $1.5 billion through the CARES Act programs, despite having billions in cash on hand.  The report found that “[h]ealthcare facilities owned by Apollo Global Management, which started the year with about $46 billion, received at least $500 million in HHS loans. And Cerberus Capital Management’s Steward Health Care System LLC, which threatened to close a hard-hit Pennsylvania hospital, received at least $400 million in loans.” 

In the letter to Secretary Azar, the Senators write:

“We ask that you require all payment recipients to provide documentation accounting for all dividends, management fees, stock repurchases, and bonuses paid (in cash or in stock) since receiving federal aid from the Provider Relief Fund. In the case of providers who have paid dividends, fees, stock repurchases, or bonuses, we ask that they provide written explanation of why these payments are consistent with the certification required by the program. Additionally, we ask that you require recipients to provide in their reports broad information about the use of funds, including an accounting of funds spent on personal protective equipment, supplies, and wages.”

A copy of the letter can be found here.

Tags: BioeconomyCOVID-19Editor PickFrontline RespondersLegislativePublic Health Emergency

Related Posts

Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
Officials Declare End to Ebola Outbreak in Uganda
Infectious Diseases

Officials Declare End to Ebola Outbreak in Uganda

January 11, 2023
A mother comforts her ill child and holds a hand to her forehead to test for temperature
Outbreak News

Strep A and Scarlet Fever: Signs and Symptoms

December 7, 2022
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC